The composition of Ehrlich's salvarsan: Resolution of a century-old debate by Lloyd, Nicholas C. et al.
Correspondence to: Professor B. K. Nicholson
Chemistry Department
University of Waikato
Private Bag 3105
Hamilton
New Zealand.
Fax 0064 7 838 4219
e-mail: b.nicholson@waikato.ac.nz
Communication
The Composition of Ehrlich’s Salvarsan; Resolution of a Century-old Debate.
Nicholas C. Lloyd, Hugh W. Morgan, Brian K. Nicholson* and Ron S. Ronimus.
[*] N. C. Lloyd, Prof. H. W. Morgan, Prof. B. K. Nicholson, Dr. R. S. Ronimus,
Departments of Chemistry and Biological Sciences,
University of Waikato,
Private Bag 3105,
Hamilton,
New Zealand.
Fax: +64 7 838 4219
E-mail: b.nicholson@waikato.ac.nz
[**] We thank the Marsden Fund, administered by the Royal Society of New Zealand,
for financial support.
________________________________________________________________________________________________
2Ehrlich introduced in 1910 the compound 3-amino-4-hydroxyphenylarsenic(I)
[Salvarsan, arsphenamine, Ehrlich 606,] as a remedy for syphilis, a disease caused by
the spirochaete bacterium Treponema pallidum. His methodical search for a specific
curative for an identified disease can be regarded as the introduction of targeted
chemotherapy.
Despite its long history and importance, the actual structure of Salvarsan is still
debated [1,2]. The compound was synthesised by Ehrlich by reaction of 3-nitro-4-
hydroxyphenylarsonic acid with dithionite [3]. This simultaneously reduced both the
–NO2 group to –NH2, and the As(V) to As(I) to give a material of stoichiometry [3-
H2N-4-HO-C6H3As] (Scheme 1). The product was isolated as the hydrated
hydrochloride salt of empirical formula [3-H2N-4-HOC6H3As.HCl.H2O]. This
synthesis was not always reproducible, and inevitably gave rise to sulfur-containing
impurities which may have accounted for the variable toxicity of different batches of
Salvarsan [4]. A two-step process involving initial reduction of the NO2 group by
sodium dithionite, followed by reduction of the As(V) with hypophosphorous acid
was subsequently shown by Christiansen to lead to sulfur-free material (Scheme 1)
[5].
By analogy with azo-compounds, Ehrlich assigned structure 1 to the free base of
Salvarsan. Although it is now recognised that As=As bonds are only found in
sterically crowded molecules [6], the As=As form is repeatedly cited, with text-books
and reviews still giving structure 1 [1,2]. Various suggestions for the true structure of
Salvarsan have been proposed, including large polycyclic molecules [7] and
polymeric versions [8], but without strong supporting data.
We now report the first definitive evidence for composition of Salvarsan, based on
electrospray mass spectrometric data.
3Salvarsan was synthesised using a modification of the two-step synthesis first
described by Christiansen [5]. The compound was isolated as the hydrochloride,
giving consistent yields of a pale-yellow material that analysed for the mono-hydrate,
corresponding exactly to Ehrlich’s original reports [9]. We also isolated the mixed
H2PO2-/H2PO3- salt (from 31P NMR) by direct precipitation from the reaction mixture.
1H and 13C NMR data were recorded for Salvarsan, but these were not particularly
useful for structural assignment. Much more indicative were electrospray mass
spectra. A typical spectrum is shown in Figure 1. Although there are many peaks,
these can be readily assigned (Table 1). Three clear series can be identified. The first
of these is the major one and consists of [(RAs)n +H]+ peaks, where R = 3-H2N-4-HO-
C6H3-, for n = 3-8, but with n = 3 and 5 being clearly dominant. Another lesser series
comprises ions generated by the loss of R- from (RAs)n, i.e. [Rn-1Asn]+ for n = 4-8.
There are also very minor peaks assignable to species [(RAs)n +O+H]+, arising from
mild oxidation presumably involving insertion of an oxygen atom into the Asn ring.
There is a significant peak [R2As]+ which is a mass-spectrometer fragmentation
product of the cyclic polyarsines (see below), and peaks [RAs(OH)2 + H]+ and
[RAs(OH)]+ from complete oxidative cleavage of the As-As bonds.
The small peak at m/z 459 is a doubly-charged ion (from the spacing in the high
resolution isotope pattern) and can be attributed to [(RAs)5+2H]2+. Similarly there is a
small overlapping contribution to the [(RAs)3+H]+ peak at m/z 550 from doubly-
protonated [(RAs)6+2H]2+ ions.
There were no features in any of the mass spectra of the type expected for higher
molecular mass polymeric compounds.
All of the evidence indicates that Salvarsan in solution consists of cyclic species
(RAs)n, with n= 3 (2) and n = 5 ( 3) the preferred size.
4We are confident that the ESMS data provides an accurate profile of the
components of Salvarsan in solution, and that the species observed are not artefacts
generated in the mass spectrometer for the following reasons.
(i) In many other areas it has been demonstrated that ESMS provides an accurate
guide to solution speciation, since the chemical ionisation process is mild and does
not lead to significant fragmentation [10]. Ions present in solution are transferred
directly into the source. This is why ES ionisation is so much more informative than
EI, FAB, or MALDI ionisation in speciation studies.
(ii) The overall ESMS profile does not change significantly with varying skimmer
cone voltage (20 -100 V), with varying pH, nor with the different electrospray
desolvation mechanisms on the two different instruments used. If the smaller rings
were being produced by fragmentation of larger molecules, then the distribution of
peaks would change markedly under the different conditions. Furthermore, when
fragmentation of the specific rings was deliberately induced by MS/MS experiments
the observed processes involved elimination of R, R2As and R3As fragments, with no
sign at all of conversion of larger rings to smaller ones.
While the ESMS results are believed to give a true qualitative reflection of the
composition of Salvarsan, quantitative allocation to different ring sizes is less certain,
since the ion signal reflects ease of chemical ionisation as well as relative abundance
[10]. However, each molecule in the series will be chemically-ionised (protonated) on
the same type of –NH2 group so a moderate correlation between signal intensity and
amount present should exist. Certainly it appears that the (RAs)3 and (RAs)5 are the
predominant molecules in the mixture, with significant (RAs)4 and (RAs)6, and only
minor representation from larger ring sizes.
5Since it has been established that other organo-arsenic(I) compounds such as
(PhAs)n and (MeAs)n can form rings [n = 5,6 for (PhAs)n, and n = 5 together with a
polymeric ladder form for (MeAs)n] [1] it is pertinent to ask why defining the
structure of Salvarsan has proved so difficult. This is due to its obdurate physical
features – the material is a mixture of compounds, it does not crystallise in a form
suitable for X-ray analysis, it is not volatile so cannot be examined by traditional mass
spectrometric methods, it is readily oxidised in solution (particularly at neutral or
higher pH) [11], and has strong H-bonding functional groups which will have
confused cryoscopic mass measurements (Salvarsan forms gels in aqueous solutions
at critical concentrations/pH [5, 15]).
We have attempted to separate Salvarsan into its constituent ring species using
HPLC experiments. However these have so far been unsuccessful, presumably
because of the high reactivity and H-bonding properties of the compound.
The (RAs)n rings formed by Salvarsan are of interest, especially the trimer since
an As3 ring does not seem to have been confirmed before, although both (RP)3 and
(RSb)3 examples are known [12]. It is striking that the trimer and pentamer appear to
be the main forms when R = 4-hydroxy-3-aminophenyl, whereas the hexamer and
pentamer are the only characterised examples for R = phenyl [1,7]. (We note that
West et al. found a peak corresponding to [(PhAs)3]+ in the EI mass spectrum of
(PhAs)n but they concluded it was a fragment ion rather than a true component of the
mixture [13]). 
 It has been accepted that Salvarsan is the administered form in clinical use but is
not the active form in vivo. Rather oxidation was needed to activate it [14]. This was
assumed to give rise to what was originally formulated as the oxide (RAs=O), but is
undoubtedly RAs(OH)2 (4) or a condensation product thereof [15]. In essence,
6Salvarsan (RAs)n appears to serve as a slow release source of RAs(OH)2. This
oxidation process was confirmed by our ESMS results. Peaks at m/z 218 and 200 can
be assigned to [RAs(OH)2+H]+ and [RAs(OH)]+, respectively (Figure 1). As the
sample was exposed to air, these signals increased in intensity at the expense of those
from the various [(RAs)n + H]+ species until after a few hours they completely
dominated the spectrum.
In conclusion, we have demonstrated for the first time that Salvarsan consists of
small rings (RAs)n, particularly 2 and 3, rather than as the commonly written form 1.
7Experimental Section
Electrospray mass spectra were recorded on VG Platform and Finnegan LCQ mass
spectrometers. For the former, the compounds were dissolved in the appropriate
solvent and injected into the spectrometer via a Rheodyne injector with a 10 mL
sample loop. A flow rate of 0.02 mL min-1 and a source temperature of 60°C was
used, and nitrogen was used as both a nebulising and drying gas. For the LCQ the
sample was directly injected into the spectrometer at 5 µL min-1 via a syringe pump.
The capillary temperature was set at 100°C, nitrogen was used as drying gas and
argon for collisionally-induced fragmentation. NMR data were recorded on a Bruker
Avance 300 spectrometer. 3-Nitro-4-hydroxyphenylarsonic acid (‘Roxarsone’) was
purchased from Aldrich.
Preparation of 3-amino-4-hydroxyphenylarsonic acid (adapted from Fargher [16]) 
3-Nitro-4-hydroxyphenylarsonic acid (13.1g, 0.05 mol) was dissolved in aqueous
NaOH solution (1 mol L-1, 100 mL) and cooled to 0ºC in an ice/salt bath. Sodium
dithionite (Na2S2O4) (30.25 g) was added in one portion with vigorous stirring. The
solution effervesced. As soon as the colour changed from orange to pale yellow,
concentrated aqueous HCl (12 mL) was added. This mixture was held at <0ºC until all
frothing ceased and the product precipitated from solution. This was filtered and
washed twice with ice-cold water to give crude 3-amino-4-hydroxyphenylarsonic acid
(6.50 g, 56%) as a cream-coloured solid. This was dried under vacuum for 24 hours.
Purification of 3-amino-4-hydroxyphenylarsonic acid (Adapted from Christiansen
[5])
The crude product (6.0 g) obtained above was dissolved in dilute aqueous HCl (H2O
25 mL, conc HCl 2 mL). This was stirred with decolourising charcoal for 15 minutes.
8The mixture was filtered and to the filtrate was added 25% sodium acetate solution
until the solution was no longer acidic to Congo Red. The solution was cooled to 4°C
for 20 minutes while the product precipitated. This was collected by filtration and
dried under vacuum to yield 3-amino-4-hydroxyphenylarsonic acid (4.7 g, 78%) as an
off-white microcrystalline solid. Elemental analysis: found C 30.76, H 3.41, N 6.32%;
calcd for C6H8AsNO4 C 30.90, H 3.43, N 6.01%. NMR (d6-DMSO) 1H:  6.97, 6.81;
13C  114.5, 115.0, 119.0, 122.6, 137.8, 148.3. ESMS (H2O): positive ion m/z 234
[M+H]+, 449 [2M-H2O+H]+, 664 [3M-2H2O+H]+; negative ion m/z 232 [M-H]-, 465
[2M-H]-, 698 [3M-H]-.
Preparation of Salvarsan [3-amino-4-hydroxyphenylarsenic(I)] (adapted from
Christiansen [5])
All solvents and solutions were degassed and the reaction was carried out under
nitrogen.
3-Amino-4-hydroxyphenylarsonic acid (2.3 g 0.01 mol) was dissolved in a solution of
hypophosphorous acid (14 mL 50%) in water (73 mL). Aqueous KI solution (1 mL of
3%) was added and the solution was heated gradually to 55ºC and held between 55
and 60º for 90 minutes. The mixture was cooled to 10ºC and poured with vigorous
stirring into cold HCl / H2O (1:1 mixture, 164 mL). Salvarsan precipitated as a pale
yellow gelatinous solid which was collected and dried under vacuum as the
hydrochloride. Elemental analysis: found C 30.66, H 3.70, N 5.62%; calcd for
C6H6AsNO.HCl.H2O: C 30.37, H 3.80, N 5.91%.
Alternatively, ethanol was added to the cooled reaction mixture after the heating step
with vigorous stirring, until a precipitate formed. The solid was collected and dried as
above, and was characterised as a mixed hypophosphite/phosphite salt of 3-amino-4-
hydroxyphenylarsenic(I). Elemental analysis: found C 27.50, H 3.92, N 5.14%; calcd
9for C6H6AsNO.H2PO2 H2O. C 26.97, H 4.12, N 5.24%; 31P NMR (D2O)  9.7 (t, 1JH-P 
536 Hz) H2PO2-,  4.1 (d, 1JH-P 648 Hz) HPO32- (ca 5:1).
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CAPTION TO FIGURE 1
The electrospray mass spectrum of Salvarsan in H2O. Peaks are annotated with m/z
values, and the ions derived from the different cycloarsines, (RAs)n, are as indicated.
Assignment of other ions is given in Table 1
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Table 1
Electrospray mass spectral data for an aqueous solution of Salvarsan.
(R = 3-NH2-4-HO-C6H3-) (c.f. Figure 1).
m/z relative assignment m/z relative assignment
int. (%) int. (%)
1465 2 [(RAs)8+H]+ 807 10 [(RAs)5-R-]+
1356 2 [(RAs)8-R-]+ 749 5 [(RAs)4O+H]+
1282 4 [(RAs)7+H]+ 733 43 [(RAs)4+H]+
1173 2 [(RAs)7-R-]+ 624 10 [(RAs)4-R-]+
1115 3 [(RAs)6O+H]+ 550 100 [(RAs)3+H]+
1099 18 [(RAs)6+H]+ 458.5 30 [(RAs)6+2H]2+
990 3 [(RAs)6-R-]+ 291 61 [R2As]+
932 5 [(RAs)5O+H]+ 218 50 [RAs(OH)2+H]+
916 90 [(RAs)5+H]+ 200 25 [RAs(OH)]+
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